BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toma L, Stancu CS, Sima AV. Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies. Biomedicines 2020;9:18. [PMID: 33375461 DOI: 10.3390/biomedicines9010018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Alenazi F, Saleem M, Syed Khaja AS, Zafar M, Alharbi MS, Al Hagbani T, Khan MY, Ahmad W, Ahmad S. Antiglycation potential of plant based TiO2 nanoparticle in D-ribose glycated BSA in vitro. Cell Biochem Funct 2022. [PMID: 36128730 DOI: 10.1002/cbf.3744] [Reference Citation Analysis]
2 Marzoog BA. Recent advances in molecular biology of metabolic syndrome pathophysiology: endothelial dysfunction as a potential therapeutic target. J Diabetes Metab Disord. [DOI: 10.1007/s40200-022-01088-y] [Reference Citation Analysis]
3 Mohd Nor NA, Budin SB, Zainalabidin S, Jalil J, Sapian S, Jubaidi FF, Mohamad Anuar NN. The Role of Polyphenol in Modulating Associated Genes in Diabetes-Induced Vascular Disorders. Int J Mol Sci 2022;23:6396. [PMID: 35742837 DOI: 10.3390/ijms23126396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Podvigina TT, Yarushkina NI, Filaretova LP. Effects of Running on the Development of Diabetes and Diabetes-Induced Complications. J Evol Biochem Phys 2022;58:174-92. [DOI: 10.1134/s0022093022010161] [Reference Citation Analysis]
5 Lorey MB, Öörni K, Kovanen PT. Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis. Front Cardiovasc Med 2022;9:841545. [DOI: 10.3389/fcvm.2022.841545] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Janjusevic M, Fluca AL, Gagno G, Pierri A, Padoan L, Sorrentino A, Beltrami AP, Sinagra G, Aleksova A. Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis. Int J Mol Sci 2022;23:2336. [PMID: 35216451 DOI: 10.3390/ijms23042336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bonilha I, Hajduch E, Luchiari B, Nadruz W, Le Goff W, Sposito AC. The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus. Metabolites 2021;11:807. [PMID: 34940565 DOI: 10.3390/metabo11120807] [Reference Citation Analysis]
8 Goetze S, Frey K, Rohrer L, Radosavljevic S, Krützfeldt J, Landmesser U, Bueter M, Pedrioli PGA, von Eckardstein A, Wollscheid B. Reproducible Determination of High-Density Lipoprotein Proteotypes. J Proteome Res 2021;20:4974-84. [PMID: 34677978 DOI: 10.1021/acs.jproteome.1c00429] [Reference Citation Analysis]
9 Jeon BH. Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021;9:1571. [PMID: 34829799 DOI: 10.3390/biomedicines9111571] [Reference Citation Analysis]
10 Smigoc Schweiger D, Battelino T, Groselj U. Sex-Related Differences in Cardiovascular Disease Risk Profile in Children and Adolescents with Type 1 Diabetes. Int J Mol Sci 2021;22:10192. [PMID: 34638531 DOI: 10.3390/ijms221910192] [Reference Citation Analysis]
11 Shahcheraghi SH, Aljabali AAA, Al Zoubi MS, Mishra V, Charbe NB, Haggag YA, Shrivastava G, Almutary AG, Alnuqaydan AM, Barh D, Dua K, Chellappan DK, Gupta G, Lotfi M, Serrano-Aroca Á, Bahar B, Mishra YK, Takayama K, Panda PK, Bakshi HA, Tambuwala MM. Overview of key molecular and pharmacological targets for diabetes and associated diseases. Life Sci 2021;278:119632. [PMID: 34019900 DOI: 10.1016/j.lfs.2021.119632] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]